Medicalsystem Biotechnologies Inc. (300439)

Overview

Medicalsystem Biotechnology Co., Ltd., headquartered in Ningbo, China, specializes in the provision of clinical diagnostics reagents and instruments catering to various healthcare needs within the country. Established in 2003, the company has grown to play a significant role in the medical diagnostics industry. Initially known as Ningbo Medicalsystem Biotechnology Co., Ltd., it underwent a name change in January 2017 to reflect its broader aspirations in the realm of biotechnology. Over the years, it has expanded its offerings to include a wide range of analytical devices and testing kits that are essential in diagnostic laboratories and healthcare facilities, marking its presence as a vital player in ensuring accurate and efficient patient care services. Furthermore, Medicalsystem Biotechnology extends its capabilities to offering healthcare services, indicating a holistic approach towards supporting health infrastructure.

Products and Services

Medicalsystem Biotechnology delivers an extensive array of products and services designed to meet the diversified needs of the healthcare industry. These include:

• Automated Biochemistry Analyzers and Bio Reagents: These instruments are designed for automated analysis of biological samples, providing essential data for disease diagnosis and monitoring. Bio reagents complement these analyzers by enabling specific biochemical tests.
• Automated Chemiluminescence Immunoassay Analyzer: A sophisticated device for performing immunoassays, useful in detecting various biomarkers in blood and other body fluids through chemiluminescence, aiding in diagnosing conditions such as infections and chronic diseases.
• Hematology Analyzers and Reagents: These are utilized for performing complete blood counts (CBC), offering vital information about the blood's components, crucial for diagnosing a wide range of conditions.
• Glycated Hemoglobin Analyzer, Blood Lipid Analyzer: Tools for monitoring diabetes and cardiovascular health by measuring glycated hemoglobin and blood lipid levels, respectively, are pivotal in managing chronic conditions.
• POCT (Point-of-Care Testing) Devices: These allow for rapid medical diagnostic testing at or near the point of care, enhancing the efficiency of medical decision-making and treatment strategies.
• Microfluidic Biochemical Analyzer: An innovative technology enabling precise analysis of biochemical substances in tiny quantities of fluid, beneficial for research and diagnostic purposes.
• Urine Analyzers and Sediment Analyzers: Instruments specifically designed for analyzing urine samples to detect and diagnose urinary tract infections, kidney diseases, and other conditions.
• PCR Kit, Antibody Test Kit, Antigen and Antibody Test Kit, and Nucleic Acid Reagent for COVID-19: A comprehensive range of testing kits for detecting SARS-CoV-2 infection, contributing significantly to global efforts in managing the COVID-19 pandemic through accurate diagnosis.

Through its holistic approach, Medicalsystem Biotechnology Co., Ltd. not only equips medical laboratories with essential diagnostics tools but also actively engages in providing healthcare services, demonstrating its commitment to enhancing patient care through innovation and quality in medical diagnostics.